Evidence map›Paper›PMID 34884566›Full record

ArticleInternational journal of molecular sciences2021

Polyaminoacid Based Core@shell Nanocarriers of 5-Fluorouracil: Synthesis, Properties and Theranostics Application.

Marta Szczęch, Alicja Hinz, Natalia Łopuszyńska, Monika Bzowska, Władysław P Węglarz, Krzysztof Szczepanowicz

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Marta SzczęchJerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, 30-239 Krakow, Poland.
Alicja HinzFaculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.
Natalia ŁopuszyńskaHenryk Niewodniczański Institute of Nuclear Physics, Polish Academy of Sciences, 31-342 Krakow, Poland.ORCID 0000-0001-7333-7200
Monika BzowskaFaculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.
Władysław P WęglarzHenryk Niewodniczański Institute of Nuclear Physics, Polish Academy of Sciences, 31-342 Krakow, Poland.ORCID 0000-0002-3390-3615
Krzysztof SzczepanowiczJerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, 30-239 Krakow, Poland.ORCID 0000-0002-9927-5869
Institute of Nuclear Physics, Polish Academy of Sciences · PLJagiellonian University · PLJerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences · PL

Funding

InterDokMed project POWR.03.02.00-00-I013/16.National Science Center 2011/03/D/ST5/05635
6 · The paper itself

Abstract

Cancer is one of the most important health problems of our population, and one of the common anticancer treatments is chemotherapy. The disadvantages of chemotherapy are related to the drug's toxic effects, which act on cancer cells and the healthy part of the body. The solution of the problem is drug encapsulation and drug targeting. The present study aimed to develop a novel method of preparing multifunctional 5-Fluorouracil (5-FU) nanocarriers and their in vitro characterization. 5-FU polyaminoacid-based core@shell nanocarriers were formed by encapsulation drug-loaded nanocores with polyaminoacids multilayer shell via layer-by-layer method. The size of prepared nanocarriers ranged between 80-200 nm. Biocompatibility of our nanocarriers as well as activity of the encapsulated drug were confirmed by MTT tests. Moreover, the ability to the real-time observation of developed nanocarriers and drug accumulation inside the target was confirmed by fluorine magnetic resonance imaging (

Indexed as

Amino AcidsAnimalsAntimetabolites, AntineoplasticDrug CarriersFemaleFluorouracilMammary Neoplasms, ExperimentalNanoparticlesTumor Cells, CulturedAmino AcidsAntimetabolites, AntineoplasticDrug CarriersFluorouracil5-Fluorouracilanticancerdrug deliveryfluorine magnetic resonance imagingnanocarrierstheranostics

Identifiers

PMID34884566
PMCPMC8657732
OpenAlexW3215112981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.